2020
DOI: 10.3390/cells9071734
|View full text |Cite
|
Sign up to set email alerts
|

Interplay of TRIM2 E3 Ubiquitin Ligase and ALIX/ESCRT Complex: Control of Developmental Plasticity During Early Neurogenesis

Abstract: Tripartite motif 2 (TRIM2) drives neurite outgrowth and polarization, is involved in axon specification, and confers neuroprotective functions during rapid ischemia. The mechanisms controlling neuronal cell fate determination and differentiation are fundamental for neural development. Here, we show that in Xenopus, trim2 knockdown affects primary neurogenesis and neural progenitor cell survival. Embryos also suffer from severe craniofacial malformation, a reduction in brain volume, and the loss of motor sensor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 40 publications
0
5
0
Order By: Relevance
“…The ubiquitin ligase TRIM2 is involved in axon growth, polarization, and specification and has neuroprotection properties. Changes in TRIM2 function have been linked to progressive neurodegeneration in Alzheimer’s patients, while its variations have been associated with childhood-onset axonal neuropathy ( 65 ). Semaphorin 5B ( SEMA5B ) functions as a guidance cue and is essential for axon guidance and growth.…”
Section: Discussionmentioning
confidence: 99%
“…The ubiquitin ligase TRIM2 is involved in axon growth, polarization, and specification and has neuroprotection properties. Changes in TRIM2 function have been linked to progressive neurodegeneration in Alzheimer’s patients, while its variations have been associated with childhood-onset axonal neuropathy ( 65 ). Semaphorin 5B ( SEMA5B ) functions as a guidance cue and is essential for axon guidance and growth.…”
Section: Discussionmentioning
confidence: 99%
“…We summarized the literature in nononcological research, as described above, concentrating mainly on the following aspects: (1) TRIM2 is regulated by the upstream miRNAs hsa-miR-18a-5p, hsa-miR-181b-5p, hsa-miR-181d-5p, and miR-181c and is associated with Pdcd6ip/Alix. In addition, TRIM2 plays a role in neuronal differentiation, axonal growth, and related nervous system diseases [18][19][20][21]. (2) TRIM2 inhibits Bim expression during rapid ischemic tolerance in the nervous system and then exerts a neuroprotective effect by regulating p42/ p44MAPK-dependent ubiquitination [14,22].…”
Section: Discussionmentioning
confidence: 99%
“…TRIM2 in Neurogenesis, Development, and Neuronal and Axonal Differentiation. Changes in TRIM2 expression have long been related to human nervous system diseases, and TRIM2 plays an important role in the nervous system [18]. Using a bioinformatics database, Su et al found that TRIM2 is an important gene that participates mainly in the regulation of the cell component tissue, axonogenesis, and cell morphogenesis during neuronal differentiation and is regulated by the upstream microRNAs (miRNAs) hsa-miR-18a-5p, hsa-miR-181b-5p, and hsa-miR-181d-5p [19].…”
Section: The Functions Of Trim2 In Nonmalignant Diseasesmentioning
confidence: 99%
See 1 more Smart Citation
“…Consistent with this hypothesis, bi-allelic loss-of-function (LoF) variants affecting multiple ESCRT subunits, including all three subunits of ESCRT-II, are not present in the general population, as observed in the Genome Aggregation Database (gnomAD). 16 To date, variants in a few of the genes encoding ESCRT subunits or associated proteins have been linked to Mendelian disorders, which are predominantly neurological diseases ( VPS37A , spastic paraplegia 53, autosomal-recessive [MIM: 614898 ]; 17 CHMP1A , pontocerebellar hypoplasia, type 8 [MIM: 614961 ]; 18 CHMP2B , frontotemporal dementia and/or amyotrophic lateral sclerosis 7 [MIM: 600795 ]; 19 PDCD6IP/ALIX , microcephaly 29, primary, autosomal-recessive [MIM: 620047 ]; 20 , 21 , 22 VPS4A , CIMDAG syndrome [MIM: 619273 ] 23 ).…”
Section: Introductionmentioning
confidence: 99%